Back to Journals » OncoTargets and Therapy » Volume 11

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

Total article views   Abstract views HTML views PDF downloads Totals
2,748 Dovepress* 2,350 209+ 412 2,559
PubMed Central* 0 189 91 189
Totals 2,350 398 503 2,748
*Since 19 April 2018
+Since July 2016

View citations on PubMed Central and Google Scholar